Manulife (Manufacturers Life Insurance)
PGEN icon

Manulife (Manufacturers Life Insurance)’s Precigen PGEN Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$519K Buy
91,097
+954
+1% +$4.12K ﹤0.01% 2232
2026
Q1 		$349K Buy
90,143
+34,137
+61% +$140K ﹤0.01% 2295
2025
Q4 		$234K Buy
56,006
+5,222
+10% +$20.2K ﹤0.01% 2448
2025
Q3 		$167K Sell
50,784
-10,004
-16% -$28.2K ﹤0.01% 2642
2025
Q2 		$86.3K Buy
60,788
+4,508
+8% +$6.41K ﹤0.01% 2795
2025
Q1 		$83.9K Buy
+56,280
New +$88.6K ﹤0.01% 2737
2024
Q3 		– Sell
-56,998
Closed -$90.1K – 3039
2024
Q2 		$90.1K Buy
56,998
+16,486
+41% +$23.9K ﹤0.01% 2849
2024
Q1 		$58.7K Buy
40,512
+14,303
+55% +$20.5K ﹤0.01% 2875
2023
Q4 		$35.1K Sell
26,209
-24,462
-48% -$28.7K ﹤0.01% 2924
2023
Q3 		$72K Buy
+50,671
New +$71.8K ﹤0.01% 2894
2023
Q2 		– Sell
-43,234
Closed -$45.8K – 3030
2023
Q1 		$45.8K Hold
43,234
– – ﹤0.01% 2874
2022
Q4 		$65.7K Buy
43,234
+21,269
+97% +$36.6K ﹤0.01% 2885
2022
Q3 		$46.6K Buy
+21,965
New +$46.3K ﹤0.01% 2918
2022
Q2 		– Sell
-45,085
Closed -$95.1K – 3104
2022
Q1 		$95.1K Sell
45,085
-9,053
-17% -$22K ﹤0.01% 2966
2021
Q4 		$201K Buy
54,138
+1,101
+2% +$4.74K ﹤0.01% 2886
2021
Q3 		$265K Sell
53,037
-2,970
-5% -$17.1K ﹤0.01% 2770
2021
Q2 		$365K Buy
56,007
+13,334
+31% +$93.2K ﹤0.01% 2656
2021
Q1 		$294K Buy
42,673
+1,032
+2% +$8.72K ﹤0.01% 2636
2020
Q4 		$425K Sell
41,641
-1,146
-3% -$7.43K ﹤0.01% 2297
2020
Q3 		$150K Hold
42,787
– – ﹤0.01% 2676
2020
Q2 		$209K Sell
42,787
-8,644
-17% -$29.4K ﹤0.01% 2475
2020
Q1 		$175K Buy
51,431
+4,778
+10% +$20.6K ﹤0.01% 2374
2019
Q4 		$256K Sell
46,653
-635
-1% -$3.57K ﹤0.01% 2430
2019
Q3 		$261K Buy
47,288
+83
+0.2% +$564 ﹤0.01% 2411
2019
Q2 		$362K Sell
47,205
-4,176
-8% -$22.5K ﹤0.01% 2249
2019
Q1 		$270K Buy
51,381
+5,767
+13% +$40K ﹤0.01% 2294
2018
Q4 		$299K Sell
45,614
-3,999
-8% -$44.8K ﹤0.01% 2168
2018
Q3 		$854K Sell
49,613
-4,066
-8% -$60.5K ﹤0.01% 1903
2018
Q2 		$748K Buy
53,679
+50,002
+1,360% +$844K ﹤0.01% 2073
2018
Q1 		$56K Sell
3,677
-79
-2% -$1.13K ﹤0.01% 3530
2017
Q4 		$43K Buy
3,756
+76
+2% +$1.13K ﹤0.01% 3575
2017
Q3 		$70K Buy
3,680
+242
+7% +$4.98K ﹤0.01% 3408
2017
Q2 		$83K Buy
3,438
+236
+7% +$5.17K ﹤0.01% 3402
2017
Q1 		$63K Sell
3,202
-29
-0.9% -$647 ﹤0.01% 3302
2016
Q4 		$77K Hold
3,231
– – ﹤0.01% 3321
2016
Q3 		$90K Hold
3,231
– – ﹤0.01% 3247
2016
Q2 		$79K Sell
3,231
-40
-1% -$1.14K ﹤0.01% 3267
2016
Q1 		$110K Buy
3,271
+262
+9% +$8.25K ﹤0.01% 3004
2015
Q4 		$90K Hold
3,009
– – ﹤0.01% 3120
2015
Q3 		$95K Sell
3,009
-22
-0.7% -$1.07K ﹤0.01% 3148
2015
Q2 		$147K Sell
3,031
-24,506
-89% -$1.03M ﹤0.01% 3117
2015
Q1 		$1.15M Buy
27,537
+2,169
+9% +$77.9K ﹤0.01% 1601
2014
Q4 		$668K Sell
25,368
-868
-3% -$19K ﹤0.01% 1820
2014
Q3 		$465K Buy
26,236
+476
+2% +$9.72K ﹤0.01% 2035
2014
Q2 		$619K Buy
25,760
+13,843
+116% +$281K ﹤0.01% 1893
2014
Q1 		$299K Sell
11,917
-157
-1% -$4.35K ﹤0.01% 2438
2013
Q4 		$275K Buy
+12,074
New +$244K ﹤0.01% 2482

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s PGEN Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Precigen (PGEN) stake by 1.1% in Q2 2026, buying an estimated $4.12K and bringing the position to 91,097 shares worth $519K. The position accounts for ﹤0.01% of the portfolio, ranked #2232.

Manulife (Manufacturers Life Insurance) first reported a position in PGEN in Q4 2013 and has held it in 47 quarters since. The position peaked at $1.15M in Q1 2015. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 91,097 shares of Precigen worth $519K as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) bought 954 Precigen shares in Q2 2026, an estimated $4.12K.
  • Precigen made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #2232 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Precigen in Q4 2013 and has held it in 47 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Precigen position peaked at $1.15M in Q1 2015.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.